Gastrointestinal Drugs Market Report

Europe Gastrointestinal Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 27, 2020
  • PAGES：219
  • REPORT CODE：GMM451261
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Gastrointestinal Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Gastrointestinal Drugs Market Segmentations:

    By Player:

    • Xian-Janssen

    • Jiangzhong

    • Sanofi

    • Teva

    • Pfizer

    • Abbott

    • Purdue Pharma

    • Perrigo

    • Zeria?Tillotts?

    • GlaxoSmithKline

    • Bayer

    • AstraZeneca

    • Boehringer Ingelheim

    By Type:

    • Prescription Gastrointestinal Drug

    • OTC Gastrointestinal Drug

    By End-User:

    • Chronic Gastritis

    • Functional Dyspepsia

    • Peptic Ulcer

    • Acute Gastroenteritis

    • Other

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Gastrointestinal Drugs Market Size and Growth Rate of Prescription Gastrointestinal Drug from 2014 to 2026

    • 1.3.2 Europe Gastrointestinal Drugs Market Size and Growth Rate of OTC Gastrointestinal Drug from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Gastrointestinal Drugs Market Size and Growth Rate of Chronic Gastritis from 2014 to 2026

    • 1.4.2 Europe Gastrointestinal Drugs Market Size and Growth Rate of Functional Dyspepsia from 2014 to 2026

    • 1.4.3 Europe Gastrointestinal Drugs Market Size and Growth Rate of Peptic Ulcer from 2014 to 2026

    • 1.4.4 Europe Gastrointestinal Drugs Market Size and Growth Rate of Acute Gastroenteritis from 2014 to 2026

    • 1.4.5 Europe Gastrointestinal Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gastrointestinal Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gastrointestinal Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Prescription Gastrointestinal Drug

      • 3.4.2 Market Size and Growth Rate of OTC Gastrointestinal Drug

    4 Segmentation of Gastrointestinal Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gastrointestinal Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gastrointestinal Drugs for Chronic Gastritis

      • 4.4.2 Market Size and Growth Rate of Gastrointestinal Drugs for Functional Dyspepsia

      • 4.4.3 Market Size and Growth Rate of Gastrointestinal Drugs for Peptic Ulcer

      • 4.4.4 Market Size and Growth Rate of Gastrointestinal Drugs for Acute Gastroenteritis

      • 4.4.5 Market Size and Growth Rate of Gastrointestinal Drugs for Other

    5 Market Analysis by Major Regions

    • 5.1 Europe Gastrointestinal Drugs Production Analysis by Top Regions

    • 5.2 Europe Gastrointestinal Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Gastrointestinal Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Gastrointestinal Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Gastrointestinal Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Gastrointestinal Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gastrointestinal Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Gastrointestinal Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Gastrointestinal Drugs Landscape Analysis

    • 7.1 Germany Gastrointestinal Drugs Landscape Analysis by Major Types

    • 7.2 Germany Gastrointestinal Drugs Landscape Analysis by Major End-Users

    8. UK Gastrointestinal Drugs Landscape Analysis

    • 8.1 UK Gastrointestinal Drugs Landscape Analysis by Major Types

    • 8.2 UK Gastrointestinal Drugs Landscape Analysis by Major End-Users

    9. France Gastrointestinal Drugs Landscape Analysis

    • 9.1 France Gastrointestinal Drugs Landscape Analysis by Major Types

    • 9.2 France Gastrointestinal Drugs Landscape Analysis by Major End-Users

    10. Italy Gastrointestinal Drugs Landscape Analysis

    • 10.1 Italy Gastrointestinal Drugs Landscape Analysis by Major Types

    • 10.2 Italy Gastrointestinal Drugs Landscape Analysis by Major End-Users

    11. Spain Gastrointestinal Drugs Landscape Analysis

    • 11.1 Spain Gastrointestinal Drugs Landscape Analysis by Major Types

    • 11.2 Spain Gastrointestinal Drugs Landscape Analysis by Major End-Users

    12. Poland Gastrointestinal Drugs Landscape Analysis

    • 12.1 Poland Gastrointestinal Drugs Landscape Analysis by Major Types

    • 12.2 Poland Gastrointestinal Drugs Landscape Analysis by Major End-Users

    13. Russia Gastrointestinal Drugs Landscape Analysis

    • 13.1 Russia Gastrointestinal Drugs Landscape Analysis by Major Types

    • 13.2 Russia Gastrointestinal Drugs Landscape Analysis by Major End-Users

    14. Switzerland Gastrointestinal Drugs Landscape Analysis

    • 14.1 Switzerland Gastrointestinal Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Gastrointestinal Drugs Landscape Analysis by Major End-Users

    15. Turkey Gastrointestinal Drugs Landscape Analysis

    • 15.1 Turkey Gastrointestinal Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Gastrointestinal Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Gastrointestinal Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Gastrointestinal Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Gastrointestinal Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Gastrointestinal Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Gastrointestinal Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Gastrointestinal Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Gastrointestinal Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Gastrointestinal Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Xian-Janssen

      • 19.1.1 Xian-Janssen Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Jiangzhong

      • 19.2.1 Jiangzhong Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Sanofi

      • 19.3.1 Sanofi Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Teva

      • 19.4.1 Teva Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Pfizer

      • 19.5.1 Pfizer Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Abbott

      • 19.6.1 Abbott Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Purdue Pharma

      • 19.7.1 Purdue Pharma Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Perrigo

      • 19.8.1 Perrigo Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Zeria?Tillotts?

      • 19.9.1 Zeria?Tillotts? Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 GlaxoSmithKline

      • 19.10.1 GlaxoSmithKline Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Bayer

      • 19.11.1 Bayer Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 AstraZeneca

      • 19.12.1 AstraZeneca Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Boehringer Ingelheim

      • 19.13.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    The List of Tables and Figures (Totals 68 Figures and 133 Tables)

    • Figure Product Picture

    • Figure Europe Gastrointestinal Drugs Market Size and Growth Rate of Prescription Gastrointestinal Drug from 2014 to 2026

    • Figure Europe Gastrointestinal Drugs Market Size and Growth Rate of OTC Gastrointestinal Drug from 2014 to 2026

    • Figure Europe Gastrointestinal Drugs Market Size and Growth Rate of Chronic Gastritis from 2014 to 2026

    • Figure Europe Gastrointestinal Drugs Market Size and Growth Rate of Functional Dyspepsia from 2014 to 2026

    • Figure Europe Gastrointestinal Drugs Market Size and Growth Rate of Peptic Ulcer from 2014 to 2026

    • Figure Europe Gastrointestinal Drugs Market Size and Growth Rate of Acute Gastroenteritis from 2014 to 2026

    • Figure Europe Gastrointestinal Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Germany Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Gastrointestinal Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gastrointestinal Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gastrointestinal Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gastrointestinal Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Gastrointestinal Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Prescription Gastrointestinal Drug

    • Figure Market Size and Growth Rate of OTC Gastrointestinal Drug

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gastrointestinal Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gastrointestinal Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Chronic Gastritis

    • Figure Market Size and Growth Rate of Functional Dyspepsia

    • Figure Market Size and Growth Rate of Peptic Ulcer

    • Figure Market Size and Growth Rate of Acute Gastroenteritis

    • Figure Market Size and Growth Rate of Other

    • Table Europe Gastrointestinal Drugs Production by Major Regions

    • Table Europe Gastrointestinal Drugs Production Share by Major Regions

    • Figure Europe Gastrointestinal Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Gastrointestinal Drugs Consumption by Major Regions

    • Table Europe Gastrointestinal Drugs Consumption Share by Major Regions

    • Table Germany Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table UK Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table France Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gastrointestinal Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Germany Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table UK Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table France Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table France Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table France Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Italy Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Spain Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Poland Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Russia Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastrointestinal Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Gastrointestinal Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Xian-Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xian-Janssen

    • Figure Sales and Growth Rate Analysis of Xian-Janssen

    • Figure Revenue and Market Share Analysis of Xian-Janssen

    • Table Product and Service Introduction of Xian-Janssen

    • Table Company Profile and Development Status of Jiangzhong

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangzhong

    • Figure Sales and Growth Rate Analysis of Jiangzhong

    • Figure Revenue and Market Share Analysis of Jiangzhong

    • Table Product and Service Introduction of Jiangzhong

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Perrigo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo

    • Figure Sales and Growth Rate Analysis of Perrigo

    • Figure Revenue and Market Share Analysis of Perrigo

    • Table Product and Service Introduction of Perrigo

    • Table Company Profile and Development Status of Zeria?Tillotts?

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zeria?Tillotts?

    • Figure Sales and Growth Rate Analysis of Zeria?Tillotts?

    • Figure Revenue and Market Share Analysis of Zeria?Tillotts?

    • Table Product and Service Introduction of Zeria?Tillotts?

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US